Navigation Links
Scripps Research scientists define cellular pathway essential to removing damaged mitochondria
Date:8/23/2011

JUPITER, FL, August 23, 2011 In a joint research effort with researchers at St. Jude Children's Research Hospital, and with help from scientists at The University of Pennsylvania, The University of Minnesota, and the National Institutes of Health, investigators from the Florida campus of The Scripps Research Institute have defined a specific protein complex that allows cells to rid themselves of damaged mitochondria, which are the energy producing machines of the cell.

"This protein complex is already being targeted in cancer therapeutics," said John Cleveland, chair of the Department of Cancer Biology at Scripps Florida, "but now we understand why some of the therapies that target this complex work and this new knowledge will have tremendous impact on both current and potential cancer therapies."

In particular, the study, which appears in the current issue of the journal Molecular Cell, focuses on how the cell uses a process known as autophagythe major recycling center of the cellto remove damaged mitochondria. The autophagy pathway is exploited by many tumors to survive stressful conditions and to remove damaged components.

The Cell under Stress

On a molecular level, the new study focuses on the role of the molecular complex known as "Hsp90-Cdc37 chaperone complex," which orchestrates various aspects of the cellular stress response. Although scientists had known that both the Hsp90-Cdc37 complex and autophagy help maintain the integrity of mitochondria, the exact relationship between Hsp90-Cdc37 and autophagy has not been well understood until the new study.

Hsp90, is a heat-shock protein, one of the cell's most abundant proteins, and assists in everything from protein folding and tumor repression to cell signaling. Cdc37, also a protein, is a co-chaperone to Hsp90 and is involved in cell signal transduction and connecting Hsp90 to the right kinases (kinases add a phosphate group to various molecules and can modify protein activity).

The study highlights the interaction between Hsp90-Cdc37 and Ulk1, a kinase that the authors show is required for the degradation and elimination of damaged mitochondria. Hsp90-Cdc37 stabilizes and activates Ulk1, which in turn phosphorylates its substrate Atg13, which is then released from the complex. Atg13 then eliminates damaged mitochondria via the autophagy pathway. Thus, the study links Hsp90-Cdc37-Ulk1-Atg13 in a direct pathway that is essential for efficient mitochondrial clearance.

"The new study shows that the key regulatory mechanism of this process is the Hsp90-Cdc37 chaperone, which functions as an on-off switch that is critical for the correct functioning of the Ulk1 kinase," Cleveland said. "Thus, if we can control this switch, we can significantly improve the therapeutic window."


'/>"/>

Contact: Eric Sauter
erics165@comcast.net
215-862-2689
Scripps Research Institute
Source:Eurekalert  

Related medicine news :

1. Scripps Translational Science Institute joins Jackson Laboratory tumor consortium
2. Scripps Research scientists show how shifts in temperature prime immune response
3. CIRM awards Scripps Research Institute scientists $3.5 million
4. Scripps Research wins more than $2 million to study prostate cancer
5. New lupus drug results from Scripps Research technology
6. Scripps Research and MIT scientists discover class of potent anti-cancer compounds
7. Scripps Research study points to liver, not brain, as origin of Alzheimers plaques
8. Scripps Research compound blocks brain cell destruction in Parkinsons disease
9. Scripps Research scientists develop powerful new methodology for stabilizing proteins
10. Scripps Research scientists find measles natural nemesis
11. Scripps Research scientists awarded $2.35 million to study new obesity treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scripps Research scientists define cellular pathway essential to removing damaged mitochondria
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors to ... Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 flip ... zones. Editors can select from a variety of flip book animations. In Addition, users ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, ... at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of ... acupuncturists to help patients realize their family building goals. Acupuncture helps fertility ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... Architecture Innovation Summit in Reston, VA on March 21-22, 2017. This premier event ... range of experiences from a cross-section of industries such as financial services, insurance, ...
(Date:12/7/2016)... Warwick, New York (PRWEB) , ... December 07, 2016 , ... ... computer professor at Yale had described him as 'a genius.'" Thus begins "Margaret in ... R. L. Rhyse and published by Wyston Books, Inc. These novels narrate ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016 Diplomat Pharmacy, Inc. (NYSE: ... five subsidiaries—American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx, ... specialty infusion services, visit diplomat.is/specialty-infusion .  ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat ... "As we continue to build ...
(Date:12/7/2016)... SCIENCE PARK , Israel , ... (TASE: KDST) announced today the signing of a memorandum of understanding ... companies. The synergy between the companies will assist in expediting Kadimastem,s ... worldwide leader in innovative treatment for severe diseases in general and ... , ...
(Date:12/7/2016)...  Based on its recent analysis of ... Sullivan recognizes Nemaura Pharma Limited with the ... Enabling Technology Leadership. Nemaura Pharma,s transdermal drug ... drug delivery technologies, especially in delivering biologics. ... technologies, Memspatch and Micropatch respectively, facilitate minimally ...
Breaking Medicine Technology: